AI주식인사이트AI Stock Insight
C

CG인바이츠

083790KOSDAQ

49.5 / 100

Reference Date: 2026-10-23

Financial Score24.0 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 7.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

CGinBites operates in pharmaceutical R&D, AI healthcare solutions, and thermal patch manufacturing, with key projects including the approved drug 'Acell克斯' and ongoing clinical trials for cancer treatments. The company leads medical innovation through precision medicine platforms based on genomic analysis and AI-driven digital healthcare solutions. It also contributes to ecosystem expansion via venture investments and startup support.

Number of Employees

92people

Average Salary

60.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.58Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
-10.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
13.45Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲163.2% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲6.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -26.3% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (16%, downtrend)

Current 894Won52-week high 1,63752-week low 744
1-month return1.0Point

1m -7.74% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral임시주주총회결과2026-09-30